Article info

Download PDFPDF
A prospective trial of adjuvant therapy for high-risk uveal melanoma: assessing 5-year survival outcomes

Authors

  1. Correspondence to Dr Arun Singh, Department of Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH 44106, USA; singha{at}ccf.org
View Full Text

Citation

Binkley E, Triozzi PL, Rybicki L, et al
A prospective trial of adjuvant therapy for high-risk uveal melanoma: assessing 5-year survival outcomes

Publication history

  • Received April 22, 2019
  • Revised July 3, 2019
  • Accepted July 6, 2019
  • First published August 1, 2019.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.